Stress-Echocardiography in Valvular Heart Diseases: Useful in Theory but Underestimated in Clinical Practice

Size: px
Start display at page:

Download "Stress-Echocardiography in Valvular Heart Diseases: Useful in Theory but Underestimated in Clinical Practice"

Transcription

1 Home SVCC Area: English - Español - Português Stress-Echocardiography in Valvular Heart Diseases: Useful in Theory but Underestimated in Clinical Practice Miguel H. Bustamante Labarta, MD Echocardiography Section - ICYCC, Fundación Favaloro, Buenos Aires, Argentina Ignorance is the night of the mind, but a night without moon or stars (Confucius) The haemodynamic behavior of regurgitant and stenotic valve lesions is closely related to the changing cardiocirculatory status. Transient variations in heart rate, preload and/or afterload are able to produce significant variations on transvalvular gradients, regurgitant volumes, stroke volumes, etc. These effects are particularly evident in those patients with more severe disease. Echocardiography has widely demonstrated to be an extremely useful tool to assess heart valve disease. Interestingly, the ordinary echocardiographic evaluation of such heart valve conditions that are so dependent on dynamic changes, is commonly and almost exclusively performed under resting conditions. In other words, it is widely recognized and accepted for most cardiologists that the evaluation of heart valve disease under a stress condition offers valuable additional information. Nevertheless, daily practice demonstrates that evaluation of these patients by means of a stress-test (ST) is not a common practice. A simple ST provides information about exercise capacity of patients with stenotic or regurgitant mitral and aortic lesions. This information is very important for choosing the optimal time for surgical treatment. Parameters of left ventricular (LV) function, such as ejection fraction (EF) and end systolic volume (ESV) have also been described as relevant information for determining the need of surgical correction. These data were initially obtained only by means of radionuclide angiography. Stress echocardiography (SE) combines the assessment of dynamic variations of clinical and electrocardiographic parameters, as in a conventional ST, and some other valuable parameters such EF and ESV, as estimated in nuclear medicine studies. Moreover, echocardiography contributes with additional valuable information in regard to cardiac anatomy (cardiac chambers dimensions, wall thickness, structure of valvular apparatus, etc.), function (ventricular performance, regurgitant mechanisms, etc.) and haemodynamic measurements (quantitation of valvular stenosis and regurgitation severity, pulmonary artery pressure, etc.). Therefore, stress-echocardiography offers the possibility of performing an integral assessment of patients with heart valve diseases under both resting and challenged haemodynamic conditions. The stress modality will depend on the type of valvular lesion to be assessed. In most cases, an exercise stress test will be the preferable choice. Dobutamine stress echocardiography (DSE) has the potential to evaluate myocardial contractile reserve in those patients with severe left ventricular dysfunction. This modality is particularly useful for unmasking severe aortic stenosis with low transvalvular gradient at rest. MITRAL REGURGITATION The biggest challenge in the management of asymptomatic (or mildly symptomatic) severe mitral regurgitation (MR) is to determine the optimal time for surgical treatment. It is well known that LV deterioration in these illness frequently develops before the onset of symptoms and even before the

2 evidence of worsening in most of the commonly used resting parameters of anatomy (LV diameters) and function (LV volumes and EF). Leung et al demonstrated the sefulness of preoperative exercise SE in predicting LV dysfunction after mitral valve repair for MR. (1) Seventy-four oligosymptomatic patients with non-rheumatic, non-ischaemic, isolated chronic MR and resting normal LVEF were included in the study. Within multivariate analysis, exercise LVESV resulted predictive of postoperative LV function. A preoperative exercise ESV greater than 25 cm²/m² was the most important predictor of postoperative dysfunction (LVEF < 50%), with a sensitivity and specificity of 83% respectively. Another important finding of these study was that all the patients that increased LVEF > 10% in exercise conserved preoperative values of LVEF after surgery. Resting LVEF was not predictive of postoperative LV systolic function in this population. These results suggest that patients with similar features than the study group that do not show exercise reduction of ESV below 25 ml/cm² and/or increase of LV in at least 5% should be considered candidates for surgical treatment. Up to date, there is not substantial information on the assessment of patients with rheumatic MR by means of SE. The evaluation of pulmonary systolic pressures under exercise conditions is an appealing option in those controversial cases where symptom status seems not to correlate with the magnitude of the MR. Large increase of systolic pulmonary pressure (SPP) under exercise is an important parameter to take in account when there is doubt about the timing of mitral valve surgery. Selected groups of patients with coronary artery disease (CAD) and unexplained episodes of dyspnea deserve to be assessed by means of a SE in the search of ischaemic MR. It is important to clarify that this special and dynamic way of presentation of MR is certainly infrequent. In fact, the majority of patients with CAD and MR present in a resting Doppler study will show reduction in the magnitude of the valvular insufficiency during SE, even those with positive ischaemic tests. (2) (Figure 1) This reduction in MR magnitude depends on many different phenomenon such as diminished afterload, significant diminution of mitral valve annulus diameter, etc. that occurs during the testing procedure. Fig 1 - The picture on the right shows an isquemic MR during a DSE. Left picture shows a mild MR observed in the resting evaluation. MITRAL STENOSIS Besides a complete resting echocardiographic study, the evaluation of the exercise capacity of a patient with MS by measures of a simple ST is one of the most important prognostic markers of the illness and a valuable tool in the decision of an interventional procedure. Nevertheless, there are particular situations where symptoms are in disagreement with the anatomic and haemodynamic data obtained from echocardiography. An example of this is the case of an asymptomatic patient with severely reduced MVA

3 (MVA), as determined by echocardiographic planimetry and/or pressure half-time (PHT), but unexplained low transvalvular gradient and low SPP. In this situation, SE may be very useful. The evidence of reduced exercise capacity, associated to a significant increase in mean transvalvular gradient and pulmonary pressure (over 15 mmhg and 60 mmhg, respectively) are strongly suggestive of severe MS. This situation may be present in patients with severe MS under a strong diuretic treatment. Thus, transvalvular gradient and pulmonary pressure may be low and symptoms may be absent despite the existence of true severe MS. In agreement with these concepts, Tunick et al reported the utility of the assessment of exercise SPP on clinical decision-making in patients with MS. (3) In this study, those patients with more severe dyspnea and lower exercise capacity presented higher exercise values of SPP. Pitfalls in Doppler estimation of MVA based on the PHT method may be important in particular situations and cardiologists should be aware of it. Thomas et al elegantly described that PHT is mainly related to the atrioventricular compliance. (4,5) This could explain those cases of true severe MS, misinterpreted as mild or moderate as a result of estimating non-severely stenotic MVA because of the presence of a relatively short PHT. In this situation, severe pulmonary hypertension and limiting symptoms are in disagreement with the apparently non severe stenosis. Although it is not frequently assessed, atrioventricular compliance may be non-invasively estimated with echocardiography and may result useful in these selected cases. Scwammenthal et al described in a subgroup of patients with MS that the presence symptoms and pulmonary hypertension despite a relatively large MVA (estimated by PHT) may be secondary to reduced atrioventricular compliance. (6) They demonstrated that there is close correlation between SPP and atrioventricular compliance. According with this, patients with a low atrioventricular compliance were more symptomatic. It has also been recognized that MVA estimated by the PHT method, tends to increase with exercise because of a decrease in atrioventricular compliance. (Fig 2) This causes a shortening in PHT that leads to overestimate the calculated area. (7) (Figure 2) Recently, Firstenberg et al reported validation and pitfalls of PHT method for the estimation of MVA in patients with MS and changes in cardiac output. In this study it was confirmed that in patients with increasing cardiac output, PHT decreased and calculated MVA increased (8) Thus, MVA estimated by the PHT in exercise is not a reliable parameter to discriminate between severe and moderate MS. The continuity equation should be the method of choice for MVA estimation while performing an SE. Fig 2- Resting and exercise mitral flow patterns in a case of mild MS. Resting parameters: Peak gradient: 9.98 mmhg, mean gradient: 3.5 mmhg, PHT: 125 mseg., MVA: 1.76 cm². Exercise parameters: Peak gradient: 28.6 mmhg, mean gradient: 11.9 mmhg, PHT: 104 mseg., MVA: 2.12 cm². In our experience, it is not necessary to perform a classic SE protocol (treadmill or bicycle). A brief and intense exercise performed bed-side or even in supine decubitus on the bed itself, is frequently enough to

4 unmask a severe MS. Another possible use for exercise SE assessment of mitral flow dynamics is in those patients treated with percutaneous transvenous mitral comissurotomy. Tamai et al described that the reduction in postprocedure resting and exercise transmitral gradient and heart rate correlated with the success of the intervention, represented by the MVA reached after dilatation. (9) A relatively unusual but controversial in its management is MS in pregnant women. In these patients, SE may be useful in predicting the haemodynamic repercussion of the disease in earlier stages of pregnancy. So, the therapeutic management of the patient could be planned earlier. To conclude, SE is certainly not necessary for the assessment of most cases of MS. On the other hand, in this article we have stressed on some different conditions where the dynamic assessment of the patient may be of great value for the decision-making procedure. AORTIC STENOSIS Most patients with severe AS are easily well identified by a conventional echocardiographic study, particularly those presenting with very high transvalvular gradients. However, the diagnosis of severe AS in those patients with severe LV dysfunction and low gradient is still a challenge for the cardiologist. A diminished cardiac output reduces the aortic transvalvular gradient and this becomes an important limitation for determining the severity of AS. Furthermore, although aortic valve area (AVA) estimated by the continuity equation is an useful option, there are some technical aspects limiting the utility of this method. In this scenario it is crucial to define those severely ill patients for whom aortic valve replacement is still the best available therapeutic option. De Filippi et al studied 18 patients with a mean resting AVA of <0.5cm 2 /m 2, mean transvalvular gradient <30mmHg and LV dysfunction. (10) Based on a low dose DSE protocol (maximal dose: 20 mg/kg/min) it was possible to identify three distinct haemodynamic subsets. Patients with non-significant AS who showed an increase in cardiac output and AVA but not in transvalvular gradient. Those with severe AS who evidenced increase in cardiac output and transvalvular gradient but not in AVA. Finally, it was not possible to determine the severity of AS in those individuals without contractile reserve, unable to increase their cardiac output. Yet, the clinical value of detecting this last subset has an important prognostic implication because these patients had a very poor prognosis. (Table 1) The decision of surgical treatment of those patient with severe AS and significant LV dysfunction is still a challenge. In our institution, a group of 19 patients with severe AS without CAD and EF 21 ± 5,4% (12-30), peak pressure gradient: 55 ± 24 mmhg (24-100), mean pressure gradient: 37 ± 16 mmhg (18-60) and AVA area: 0,5± 0,4cm 2 (0,3-08) underwent aortic valve replacement. Hospital mortality was 5,2% (1/19 patients) and follow- up survival at 37 months (mean 13.6±8.3 months) of the remaining patients was 100%. (11) Based on this experience, it is in our opinion that, except for particular cases, patients with severe AS without significant CAD and reduced LVEF should not be excluded from aortic valve

5 replacement, no matter how low ejection fraction and pressure gradients are. AORTIC REGURGITATION Bonow et al. demonstrated that preoperative exercise capacity in symptomatic patients with AR was predictive of postoperative LV function and long-term prognosis after aortic valve surgery. (12) A different issue appears while analyzing EF response to exercise. It has been described that patients who fail to increase LV ejection fraction with exercise tend to have a faster progression to symptoms. It has also been reported that lack of improvement in EF under exercise has a high sensitivity but a low specificity for predicting bad prognosis after aortic valve surgery. It is important to stress on the relative value of assessing exercise EF as a reliable parameter of LV systolic function based on the limitations of the EF as a real expression of myocardial contractility. (13,14) The decrease in vascular resistance and shortening in diastolic period during exercise may reduce aortic regurgitant volume. Then, lack of increase or even a decrease in EF may simply be an expression of a significant reduction in diastolic volume and not a real marker of contractile reserve. To date, AR is, maybe, the valvular heart lesion in witch SE offers less diagnostic utility. Nonetheless, it is interesting to discuss about some aspects of the implementation of this technique in such fascinating valvular disease. Early detection of myocardial dysfunction in asymptomatic patients with chronic severe AR and seek of prognostic markers of postoperative outcome are some of the many still unresolved issues. Some echocardiographic parameters of LV function (fractional shortening, end systolic diameter, wall stress, etc.) have been described as prognostic markers of postoperative outcome. Associated to clinical parameters, these measurements are routinely used to decide the optimal time for surgical intervention. Unfortunately, none of these parameters are either highly sensitive or specific in terms of prognostic value. DSE has been demonstrated useful in the evaluation of patients with severe aortic stenosis and LV dysfunction. However, this inotropic agent has not currently been used for the study of patients with AR. The detection of contractile reserve in AR with LV systolic dysfunction by means of analyzing the inotropic response to dobutamine stimulus and its prognostic value after valvular surgery is an attractive field yet to be investigated. In the ICYCC-Fundación Favaloro, 28 patients with chronic severe AR and LV deterioration (EF under 60% - mean value: 39.1±10.5) were prospectively studied with low dose DSE (5 minutes stages of 5, 10 and eventually 15 mg/kg/min) immediately before aortic valve surgery. (15) The goal of this study was to analyze if the effects of dobutamine administration on preoperative LVEF and ESV were predictive of early (first 24 hours) postoperative complications related to pump failure (death, difficulties in cardiopulmonary by-pass weaning and need of mechanical assisted circulation and/or two or more inotropic drugs). Against the original hypothesis, LV response to dobutamine was not predictive of postoperative early complications. Postoperative events only correlated with age and preoperative fractional shortening. Even so, some investigators have reported the utility of DSE in predicting postoperative recovery of LV function in AR. Wahi et al studied 61 patients with asymptomatic or minimally symptomatic AR and not know CAD (16). Exercise EF was evaluated with echocardiography. Patients who showed improved exercise EF were defined as having contractile reserve (CR+). Those without increment of EF were defined as CR-. Thirtyfive patients were medically treated and the remaining 26 patients had surgical treatment. In the medically treated patients, 13 of 21 (62%) with CR+ had preserved EF on follow-up. In the CR- subgroup, 13 of 14 patients had EF deterioration on follow-up (p=0.005). Among the surgery group, 13 showed CR+. All these patients had an increase in EF on follow-up. Of 13 remaining patient with CR-, 10 showed the

6 same or worse EF on postoperative follow-up. Thus, contractile reserve assessed by exercise SE resulted to be a better predictor of postoperative LVF than resting parameters in asymptomatic individuals with chronic AR. In those patients undergoing aortic valve replacement, contractile reserve had a better correlation with resting EF on postoperative follow-up. These findings are encouraging enough to suggest the use of exercise SE in asymptomatic patients with severe AR as a valuable tool in the timing for surgery. In our opinion the helpfulness of SE in AR is an attractive field that still needs to be explored. FINAL CONSIDERATIONS This article does not intend to discover a new way to assess patients with heart valve diseases. Definitively, SE is not the first diagnostic step in the ladder to evaluate cardiac valvular lesions. But, it may become a vital supplementary diagnostic tool, particularly in those controversial cases where timing for clinical-making decisions is crucial. The strong influence of cardiocirculatory dynamic conditions on valvular gradients, regurgitant volumes, stroke volume, pulmonary pressure, symptoms, etc., is one of the reasons that makes the assessment of heart valve diseases so exciting. Therefore, cardiologists would not be pleased of understanding such diverse changing physiopathology just by evaluating patients in resting conditions. Finally, we should understand that SE is not only a synonym of dynamic assessment of patients with CAD but also an open window to the comprehension of some other cardiac diseases. REFERENCES 1. Leung DY, Griffin BP, Stewart WJ, Cosgrove DM 3rd, Thomas JD, Marwick TH. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 1996 Nov 1;28(5): Heinle SK, Tice FD, Kisslo J. Effect on dobutamine stress echocardiography on mitral regurgitation. J Am Coll Cardiol 1995;25: Tunick PA, Freedberg RS, Gargiulo A, Kronzon I. Exercise Doppler echocardiography as an aid to clinical decision making in mitral valve disease. J Am Soc Echocardiogr 1992;5: Thomas JD, Weyman AE. Doppler mitral pressure half-time: a clinical tool in search of theoretical justification. J Am Coll Cardiol 1987;10(4): Thomas JD, Wilkins GT, Choong CY, Abascal VM, Palacios IF, Block PC et al. Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance. Circulation 1988;78(4): Scwammenthal E, Vered Z, Agranat O, Kaplinsky E, Rabinowitz B, Feinberg MS. Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation 2000;102: Braverman AC, Thomas JD, Lee RT. Doppler echocardiographic estimation of mitral valve area during changing haemodynamic conditions. Am J Cardiol 1991;68(15): Firstenberg MS, Prior DL, Greenberg NL Wahi S, Pasquet A, Garcia MJ et al. Effect of cardiac output on mitral valve area in patients with mitral stenosis: validation and pitfalls of the pressure half-time method. J Heart Valve Dis 2001;10: Tamai J, Nagata S, Akaike M, Ishikura F, Kimura K, Takamiya M et al. Improvement in mitral flow dynamics during exercise after percutaneous transvenous mitral comissurotomy. Non-invasive evaluation using continuous wave Doppler technique. Circulation 1990;81: defilippi CR, Willett DL, Brickner E, Appleton CP, Yancy CW, Eichhorn EJ et al. Usefulness of dobutamine echocardiography in distinguishing severe from non severe valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995;75: Casabe H, Stutzbach P, Guevara E, Gomez C, Machain A, Favaloro M et al. Outcome of aortic valve replacement in patients with severe aortic stenosis without significant coronary artery disease and severely depressed left ventricular function. J Am Coll Cardiol 2000; 35(Suppl A): Bonow RO, Borer JS, Rosing DR, Henry WL, Pearlman AS, McIntosh CL et al. Preoperative exercise capacity in symptomatic patients with aortic regurgitation as a predictor of postoperative left ventricular function and long-term prognosis. Circulation 1980;62(6): Borer JS, Bacharach SL, Green MV, Kent KM, Henry WL, Rosing DR et al. Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide

7 cineangiography. Am J Cardiol 1978;42(3): Boucher CA, Kanarek DJ, Okada RD, Hutter AM, Strauss HW, Pohost GM. Exercise testing in aortic regurgitation: Comparison of radionucleide left ventricular ejection fraction with exercise performance at the anaerobic threshold and peak exercise. Am J Cardiol 1983;52: Bustamante Labarta M, Miranda A, Perrone S, Comtesse D, Favaloro RR, Stutzbach P et al. Insuficiencia aórtica severa con disfunción ventricular: Parámetros basales del Eco-Doppler versus test de Eco-Dobutamina en la predicción de complicaciones de la cirugía valvular. Rev Arg Cardiol 1999;67(Suppl 3): Wahi S, Haluska B, Pasquet A, Case C, Rimmerman CM, Marwick TH. Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asymptomatic severe aortic regurgitation. Heart 2000;84: Top Your questions, contributions and commentaries will be answered by the lecturer or experts on the subject in the Echocardiography list. Please fill in the form (in Spanish, Portuguese or English) and press the "Send" button. Question, contribution or commentary: Name and Surname: Country: address: Send Erase Top 2nd Virtual Congress of Cardiology Dr. Florencio Garófalo Steering Committee President fgaro@fac.org.ar fgaro@satlink.com Dr. Raúl Bretal Scientific Committee President rbretal@fac.org.ar rbretal@netverk.com.ar Dr. Armando Pacher Technical Committee - CETIFAC President apacher@fac.org.ar apacher@satlink.com Copyright Argentine Federation of Cardiology All rights reserved This company contributed to the Congress

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction Role of Stress Echo in Valvular Heart Disease ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan Not only ischemia! Cardiomyopathy Prosthetic Valve Diastolic

More information

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic Load and Function - Valvular Heart Disease Tom Marwick, Cardiovascular Imaging Cleveland Clinic Indications for surgery in common valve lesions Risks Operative mortality Failed repair - to MVR Operative

More information

Michigan Society of Echocardiography 30 th Year Jubilee

Michigan Society of Echocardiography 30 th Year Jubilee Michigan Society of Echocardiography 30 th Year Jubilee Stress Echocardiography in Valvular Heart Disease Moving Beyond CAD Karthik Ananthasubramaniam, MD FRCP (Glas) FACC FASE FASNC Associate Professor

More information

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload

More information

Hypertension in Aortic Valve Disease

Hypertension in Aortic Valve Disease Hypertension in Aortic Valve Disease Hanna M. Nosseir MRCP, FRCP Head of Cardiology department Galaa Military Medical Complex Aortic stenosis: Introduction Arterial hypertension and aortic stenosis are

More information

Aortic stenosis aetiology: morphology of calcific AS,

Aortic stenosis aetiology: morphology of calcific AS, How to improve patient selection in aortic stenosis? Fausto J. Pinto, FESC Aortic stenosis aetiology: morphology of calcific AS, bicuspid valve, and rheumatic AS (Adapted from C. Otto, Principles of

More information

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010 Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets

More information

Tobacco Consumption and Acute Myocardial Infarction

Tobacco Consumption and Acute Myocardial Infarction Home SVCC Area: English - Español - Português Tobacco Consumption and Acute Myocardial Infarction Bianco, Eduardo; Cobas, Joaquín Cardiac Care Unit (CCU), Asociación Española Primera de Socorros Mutuos.

More information

Asymptomatic Valvular Disease:

Asymptomatic Valvular Disease: Asymptomatic Valvular Disease: Can Echocardiography Help You Decide When to Intervene? Neil J. Weissman, MD MedStar Health Research Inst at MedStar Washington Hospital Center & Professor of Medicine Georgetown

More information

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central Michigan University

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology Aortic Stenosis: UPDATE 2010 Anjan Sinha, MD Krannert Institute of Cardiology None Disclosures 67-Year-Old Male Dyspnea and angina Class III heart failure No PND or orthopnea 3/6 late peak SEM Diminished

More information

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment Stefanos Karagiannis MD PhD Cardiologist Director Echocardiology Dpt Athens Medical Center ESC 2017

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants Martin G. Keane, MD, FASE Professor of Medicine Lewis Katz School of Medicine at Temple University Basic root structure Parasternal

More information

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

2019 Qualified Clinical Data Registry (QCDR) Performance Measures 2019 Qualified Clinical Data Registry (QCDR) Performance Measures Description: This document contains the 18 performance measures approved by CMS for inclusion in the 2019 Qualified Clinical Data Registry

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Aortic stenosis (AS) is common with the aging population.

Aortic stenosis (AS) is common with the aging population. New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting

More information

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 1 Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Cardiovascular Effects of Pregnancy Anatomic Ventricular muscle mass increases

More information

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES THORAXCENTRE DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES J. Roelandt DOPPLER HEMODYNAMICS Intracardiac pressures and pressure gradients Volumetric measurement

More information

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30. Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation

More information

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Severe left ventricular dysfunction and valvular heart disease: should we operate? Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict

More information

Cardiovascular Imaging Stress Echo

Cardiovascular Imaging Stress Echo Cardiovascular Imaging Stress Echo Theodora A Zaglavara, MD, PhD Cardiac Imaging Department INTERBALKAN MEDICAL CENTER Thessaloniki GREECE Evolution of Stress Echo: From Innovation to a Widely Established

More information

Valvular Guidelines: The Past, the Present, the Future

Valvular Guidelines: The Past, the Present, the Future Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,

More information

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Role of Stress Echo in Valvular Heart Disease Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Exercise echocardiography Dobutamine echocardiography Usefulness of exercise echo

More information

Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Original Article

Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Original Article Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Abstract Arezoo Khosravi (1), Hadi Sheykhloo (2), Reza Karbasi-Afshar (1), Amin Saburi (3) Original

More information

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Corrective Surgery in Severe Heart Failure Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Session Objectives 1.) Identify which patients with severe

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics Hemodynamic Assessment Matt M. Umland, RDCS, FASE Aurora Medical Group Milwaukee, WI Assessment of Systolic Function Doppler Hemodynamics Stroke Volume Cardiac Output Cardiac Index Tei Index/Index of myocardial

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation Imaging Assessment of Aortic Stenosis/Aortic Regurgitation Craig E Fleishman, MD FACC FASE The Heart Center at Arnold Palmer Hospital for Children, Orlando SCAI Fall Fellows Course 2014 Las Vegas Disclosure

More information

TAVR: Echo Measurements Pre, Post And Intra Procedure

TAVR: Echo Measurements Pre, Post And Intra Procedure 2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery

Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery Aortic stenosis (AS) is characterized as a high-risk index for cardiac complications during non-cardiac surgery. A critical analysis of old

More information

Value of echocardiography in chronic dyspnea

Value of echocardiography in chronic dyspnea Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting

More information

An Integrated Approach to Study LV Diastolic Function

An Integrated Approach to Study LV Diastolic Function An Integrated Approach to Study LV Diastolic Function Assoc. Prof. Adriana Ilieşiu, FESC University of Medicine Carol Davila Bucharest, Romania LV Diastolic Dysfunction impaired relaxation (early diastole)

More information

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO Jean-Luc MONIN, MD, PhD Henri Mondor University Hospital Créteil, FRANCE Potential conflicts of interest

More information

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey Interatrial Block and P-Terminal Force: A Reflection of Mitral Stenosis Severity on Electrocardiography Murat Yuce 1, Vedat Davutoglu 1, Cayan Akkoyun 1, Nese Kizilkan 2, Suleyman Ercan 1, Murat Akcay

More information

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR William A. Zoghbi MD, FASE, MACC Professor and

More information

Echocardiography: Guidelines for Valve Quantification

Echocardiography: Guidelines for Valve Quantification Echocardiography: Guidelines for Echocardiography: Guidelines for Chamber Quantification British Society of Echocardiography Education Committee Richard Steeds (Chair), Gill Wharton (Lead Author), Jane

More information

History of Stress Testing. Disclosure. Overview. Stress Echocardiography New Applications. and Comparison with Other Stress.

History of Stress Testing. Disclosure. Overview. Stress Echocardiography New Applications. and Comparison with Other Stress. Stress Echocardiography New Applications and Comparison with Other Stress Modalities Robert T. Palac, MD April 28, 2016 Overview Stress Testing Basics Stress Echocardiography and Stress Nuclear Perfusion

More information

LV Function Cardiac Output EPSS

LV Function Cardiac Output EPSS LV Function Cardiac Output EPSS Mike Mallin, MD Why is LV function important? Systolic Dysfunction is bad... Is it worse? Is it the cause of my patients dyspnea? Does my patient need a inotrope? Why is

More information

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter. Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP North Shore HS, LIJ/Lenox Hill Hospital, New York

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Author Proof. [3]. Exercise testing is strongly advocated in the European Society of Cardiology (ESC) guidelines

Author Proof. [3]. Exercise testing is strongly advocated in the European Society of Cardiology (ESC) guidelines Stress testing in valvular heart disease: clinical benefit of echocardiographic imaging Monica Roşca 1,2, Patrizio Lancellotti 1, Julien Magne 1 and Luc A Piérard 1 1 Department of Cardiology, University

More information

Stress Testing in Valvular Disease

Stress Testing in Valvular Disease 2017 ASE Florida Orlando, FL October 10, 2017 2:40 2:50 PM 10 min Grand Harbor Ballroom South Stress Testing in Valvular Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography

More information

The Patient with Atrial Fibrilation

The Patient with Atrial Fibrilation Assessment of Diastolic Function The Patient with Atrial Fibrilation Assoc. Prof. Adriana Ilieşiu, FESC University of Medicine Carol Davila Bucharest, Romania Associated Conditions with Atrial Fibrillation

More information

Abstract ESC Pisa

Abstract ESC Pisa Abstract ESC 82441 Maximal left ventricular mass-to-power output: A novel index to assess left ventricular performance and to predict outcome in patients with advanced heart failure FL. Dini 1, D. Mele

More information

Comprehensive Echo Assessment of Aortic Stenosis

Comprehensive Echo Assessment of Aortic Stenosis Comprehensive Echo Assessment of Aortic Stenosis Smonporn Boonyaratavej, MD, MSc King Chulalongkorn Memorial Hospital Bangkok, Thailand Management of Valvular AS Medical and interventional approaches to

More information

Patients with severe aortic stenosis (AS), left ventricular

Patients with severe aortic stenosis (AS), left ventricular Low-Gradient Aortic Stenosis Operative Risk Stratification and Predictors for Long-Term Outcome: A Multicenter Study Using Dobutamine Stress Hemodynamics Jean-Luc Monin, MD; Jean-Paul Quéré, MD; Mehran

More information

Managing the Low Output Low Gradient Aortic Stenosis Patient

Managing the Low Output Low Gradient Aortic Stenosis Patient Managing the Low Output Low Gradient Aortic Stenosis Patient R A Nishimura MD Judd and Mary Leighton Professor of CV Mayo Clinic No disclosures Valvular Stenosis Severity of Aortic Stenosis Mean gradient

More information

E/Ea is NOT an essential estimator of LV filling pressures

E/Ea is NOT an essential estimator of LV filling pressures Euroecho Kopenhagen Echo in Resynchronization in 2010 E/Ea is NOT an essential estimator of LV filling pressures Wilfried Mullens, MD, PhD December 10, 2010 Ziekenhuis Oost Limburg Genk University Hasselt

More information

Predictors of Major Cardiac Events in the Late Follow-Up in Patients Treated With PTCA During Q Wave AMI

Predictors of Major Cardiac Events in the Late Follow-Up in Patients Treated With PTCA During Q Wave AMI Home SVCC Area: English - Español - Português Predictors of Major Cardiac Events in the Late Follow-Up in Patients Treated With PTCA During Q Wave AMI Torresani, E.M.; Weisshein, N.; Martino, G.; Hrabar,

More information

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University

More information

Natural History and Echo Evaluation of Aortic Stenosis

Natural History and Echo Evaluation of Aortic Stenosis Natural History and Echo Evaluation of Aortic Stenosis Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM AORTIC STENOSIS First valvular disease

More information

Cardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007

Cardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007 Cardiac Output MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 90- Guided by Ohm's law when : a- Cardiac output = 5.6 L/min. b- Systolic and diastolic BP

More information

Hemodynamics of Exercise

Hemodynamics of Exercise Hemodynamics of Exercise Joe M. Moody, Jr, MD UTHSCSA and ALMMVAH, STVAHCS Exercise Physiology - Acute Effects Cardiac Output (Stroke volume, Heart Rate ) Oxygen Extraction (Arteriovenous O 2 difference,

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

Right Atrial Size and Tricuspid Regurgitation Severity Predict Mortality or Transplantation in Primary Pulmonary Hypertension

Right Atrial Size and Tricuspid Regurgitation Severity Predict Mortality or Transplantation in Primary Pulmonary Hypertension Right Atrial Size and Tricuspid Regurgitation Severity Predict Mortality or Transplantation in Primary Pulmonary Hypertension Miguel Bustamante-Labarta, MD, Sergio Perrone, MD, Ricardo Leon de la Fuente,

More information

Course Learning Objectives Sunday, February 17 Friday, February 22

Course Learning Objectives Sunday, February 17 Friday, February 22 Course Learning Objectives Sunday, February 17 Friday, February 22 1. Define the physical principles of ultrasound technology and its applications for two and threedimensional (2D, 3D) imaging and use

More information

Which one of the following echocardiographic profiles most strongly indicates the need for aortic valve replacement? FS [

Which one of the following echocardiographic profiles most strongly indicates the need for aortic valve replacement? FS [ Question 46 A 45-year-old asymptomatic man returns for follow-up. He was diagnosed 10 years ago with aortic regurgitation due to a congentia lbicuspid aortic valve, He has never had endocarditis Which

More information

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with Echocardiography Guidelines for Valve and Chamber Quantification In partnership with Explanatory note & references These guidelines have been developed by the Education Committee of the British Society

More information

Echocardiography as a diagnostic and management tool in medical emergencies

Echocardiography as a diagnostic and management tool in medical emergencies Echocardiography as a diagnostic and management tool in medical emergencies Frank van der Heusen MD Department of Anesthesia and perioperative Care UCSF Medical Center Objective of this presentation Indications

More information

ORIGINAL INVESTIGATION. Aortic Valve Replacement in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

ORIGINAL INVESTIGATION. Aortic Valve Replacement in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction ORIGINAL INVESTIGATION Aortic Valve Replacement in With Aortic Stenosis and Severe Left Ventricular Dysfunction David E. Powell, MD; Paul A. Tunick, MD; Barry P. Rosenzweig, MD; Robin S. Freedberg, MD;

More information

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes Aortic valve Stenosis: Insights in the evaluation of LV function Erwan DONAL Cardiologie CHU Rennes erwan.donal@chu-rennes.fr Preload Afterload Myocardial Fiber Shortening Circumferential Longitudinal

More information

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP Northwell, Lenox Hill Hospital, New York Professor of Cardiology Hofstra University

More information

USE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS

USE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS USE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS Prof. Gerald Yonga MBChB, MMed, MBA, FRCP(Edin),FESC, FACC Aga Khan University Hospital Nairobi, Kenya. RHEUMATIC HEART

More information

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Rahul R. Jhaveri, MD, Muhamed Saric, MD, PhD, FASE, and Itzhak Kronzon, MD, FASE, New York, New York Background: Two-dimensional

More information

Objectives. Diastology: What the Radiologist Needs to Know. LV Diastolic Function: Introduction. LV Diastolic Function: Introduction

Objectives. Diastology: What the Radiologist Needs to Know. LV Diastolic Function: Introduction. LV Diastolic Function: Introduction Objectives Diastology: What the Radiologist Needs to Know. Jacobo Kirsch, MD Cardiopulmonary Imaging, Section Head Division of Radiology Cleveland Clinic Florida Weston, FL To review the physiology and

More information

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts

More information

REVIEW ARTICLE PROGRESS IN STRESS ECHOCARDIOGRAPHY. Application of Stress Echocardiography to the Evaluation of Non-coronary Heart Disease

REVIEW ARTICLE PROGRESS IN STRESS ECHOCARDIOGRAPHY. Application of Stress Echocardiography to the Evaluation of Non-coronary Heart Disease Eur J Echocardiography (2000) 1, 171 179 doi:10.1053/euje.2000.0038, available online at http://www.idealibrary.com on REVIEW ARTICLE PROGRESS IN STRESS ECHOCARDIOGRAPHY Application of Stress Echocardiography

More information

Echo Week - Learning Objectives

Echo Week - Learning Objectives Echo Week - Learning Objectives Sunday, February 25 5-7 pm Physics Review Moderator: Mark Taylor, MD 1. Understand the ultrasound physics and apply it to image creation and optimization 2. Infer the interaction

More information

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines - Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS Low-flow and Other Challenges to the Assessment of Aortic Stenosis Nithima Ratanasit, MD, FACC, FASE Siriraj Hospital, Mahidol University Bangkok, Thailand Outline Types of low-flow aortic stenosis Assessment

More information

Left atrial function. Aliakbar Arvandi MD

Left atrial function. Aliakbar Arvandi MD In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial

More information

Organic mitral regurgitation

Organic mitral regurgitation The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality

More information

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM Conflict of Interest Disclosure None Why to assess LV function in asymptomatic

More information

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC No Financial Disclosures Aortic Stenosis AS is an insidious disease with a long latency period followed by

More information

Aortic Regurgitation & Aorta Evaluation

Aortic Regurgitation & Aorta Evaluation VALVULAR HEART DISEASE Regurgitation Valvular Lessions 2017 Aortic Regurgitation & Aorta Evaluation Jorge Eduardo Cossío-Aranda MD, FACC Chairman of Outpatient Care Department Instituto Nacional de Cardiología

More information

Survival Benefit of Aortic Valve Replacement in Older Patients With Asymptomatic Chronic Severe Aortic Regurgitation

Survival Benefit of Aortic Valve Replacement in Older Patients With Asymptomatic Chronic Severe Aortic Regurgitation Survival Benefit of Aortic Valve Replacement in Older Patients With Asymptomatic Chronic Severe Aortic Regurgitation Rami Turk, MD, Padmini Varadarajan, MD, Ashvin Kamath, BA, Unnati Sampat, MD, Sumit

More information

Advanced imaging of the left atrium - strain, CT, 3D, MRI -

Advanced imaging of the left atrium - strain, CT, 3D, MRI - Advanced imaging of the left atrium - strain, CT, 3D, MRI - Monica Rosca, MD Carol Davila University of Medicine and Pharmacy, Bucharest, Romania Declaration of interest: I have nothing to declare Case

More information

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function J A F E R A L I, M D U N I V E R S I T Y H O S P I T A L S C A S E M E D I C A L C E N T E R S T A F F C A R D I O T

More information

Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy

Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania My conflicts of interest: I have

More information

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? Prof. Patrizio LANCELLOTTI, MD, PhD GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège, CHU

More information

Elections to EACVI Board

Elections to EACVI Board Elections to EACVI Board 2018-2020 Application for the position: EACVI President-Elect Insert your photo here 1. Your Identity Title Family Name(s) Professor Flachskampf First Name(s) Frank A. Birth Date

More information

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular

More information

Indicator Mild Moderate Severe

Indicator Mild Moderate Severe Indicator Mild Moderate Severe Jet velocity (m/s) 2.0-2.9 3.0-3.9 4.0 Mean gradient (mmhg) < 20 20-39 40 Valve area (cm 2 ) 1.0 Valve area index (cm 2 /m 2 ) 0.6 1 Abnormal AV with Reduced Systolic Opening

More information

Spotlight on Valvular Heart Disease Guidelines

Spotlight on Valvular Heart Disease Guidelines Spotlight on Valvular Heart Disease Guidelines Aortic Valve Disease Raphael Rosenhek Department of Cardiology Medical University of Vienna Palermo, April 26 th 2018 1998 2002 2006 2007 2008 2012 2014 2017

More information

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer «Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Université LAVAL

More information

SONOGRAPHER & NURSE LED VALVE CLINICS

SONOGRAPHER & NURSE LED VALVE CLINICS SONOGRAPHER & NURSE LED VALVE CLINICS Frequency of visits and alerts AORTIC STENOSIS V max > 4.0 m/s or EOA < 1.0 cm 2 V max 3.5 4.0 m/s + Ca+ V max 3.0 4.0 m/s or EOA 1.0-1.5 cm 2 V max 2.5 3.0 m/s every

More information

MITRAL STENOSIS. Joanne Cusack

MITRAL STENOSIS. Joanne Cusack MITRAL STENOSIS Joanne Cusack BSE Breakdown Recognition of rheumatic mitral stenosis Qualitative description of valve and sub-valve calcification and fibrosis Measurement of orifice area by planimetry

More information

Nomograms for severity of aortic valve stenosis using peak aortic valve pressure gradient and left ventricular ejection fraction

Nomograms for severity of aortic valve stenosis using peak aortic valve pressure gradient and left ventricular ejection fraction European Journal of Echocardiography (2009) 10, 532 536 doi:10.1093/ejechocard/jen333 Nomograms for severity of aortic valve stenosis using peak aortic valve pressure gradient and left ventricular ejection

More information

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine Director, Structural Heart Imaging The Ohio State University

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Low Gradient Severe? AS

Low Gradient Severe? AS Low Gradient Severe? AS Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Institut Universitaire de Cardiologie et de Pneumologie de Québec / Québec Heart

More information

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece Jean-Luc MONIN, MD, PhD. University Hospital, Créteil, FRANCE My disclosures: Lecture and/ or consulting

More information

P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation

P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation Comprehensive Hemodynamic Evaluation by Doppler Echocardiography Itzhak Kronzon, MD North Shore LIJ/ Lenox Hill Hospital New York, NY Disclosure: Philips Healthcare St. Jude Medical The Simplified Bernoulli

More information

Mitral Valve Stenosis: What do I need to know? ACC Latin American Conference 2017

Mitral Valve Stenosis: What do I need to know? ACC Latin American Conference 2017 Mitral Valve Stenosis: What do I need to know? ACC Latin American Conference 2017 Athena Poppas, MD FACC FASE Past ACC Scientific Sessions Chair, ACC Board of Trustee Professor of Medicine, Brown University

More information